Top Page
Costain
(LSE:COST)
Costain (COST) vs. iShares MSCI United Kingdom ETF (EWC)
Costain Business Overview & Revenue Model
Costain Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 1.25B | 1.33B | 1.42B | 1.14B | 978.40M | Gross Profit |
| 103.30M | 103.50M | 82.20M | 39.10M | -59.10M | EBIT |
| 31.10M | 34.80M | 46.30M | -9.50M | -81.10M | EBITDA |
| 52.60M | 50.90M | 47.20M | 4.60M | -65.10M | Net Income Common Stockholders |
| 30.60M | 22.10M | 25.90M | -5.80M | -78.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 158.50M | 164.40M | 123.80M | 159.40M | 150.90M | Total Assets |
| 547.20M | 468.60M | 482.20M | 532.40M | 489.90M | Total Debt |
| 25.80M | 24.30M | 24.10M | 66.20M | 80.10M | Net Debt |
| -132.70M | -140.10M | -99.70M | -93.20M | -70.80M | Total Liabilities |
| 311.50M | 249.20M | 271.00M | 333.40M | 333.40M | Stockholders Equity |
| 235.70M | 219.40M | 211.20M | 199.00M | 156.50M |
| Cash Flow | Free Cash Flow | |||
| 37.20M | 55.60M | 13.60M | 27.30M | -50.90M | Operating Cash Flow |
| 42.70M | 55.70M | 14.10M | 29.50M | -46.80M | Investing Cash Flow |
| -9.00M | -100.00K | -1.30M | -2.20M | 4.50M | Financing Cash Flow |
| -25.60M | -15.00M | -48.40M | -18.80M | 12.90M |
Costain Technical Analysis
Costain Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £668.87M | 14.78 | 22.62% | 2.23% | 3.23% | 2.00% | |
77 Outperform | £335.26M | 10.90 | 13.45% | 1.92% | -6.07% | 41.18% | |
77 Outperform | £408.37M | 10.38 | 35.97% | 4.07% | 22.39% | 179.53% | |
77 Outperform | £1.76B | 13.34 | 21.67% | 3.50% | 10.41% | 11.04% | |
75 Outperform | £705.82M | 16.54 | 10.20% | 3.33% | 8.04% | 6.94% | |
74 Outperform | £2.49B | 14.60 | 15.35% | 2.37% | 3.02% | -3.23% | |
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% |
Costain Corporate Events
Ennismore Fund Management Limited has adjusted its holdings in Costain Group PLC, reducing its voting rights from 6.56% to 5.82%. This change, notified on May 19, 2025, reflects a strategic shift in Ennismore’s investment approach, potentially impacting Costain’s shareholder dynamics and market perception.
The most recent analyst rating on (GB:COST) stock is a Hold with a £1.05 price target. To see the full list of analyst forecasts on Costain stock, see the GB:COST Stock Forecast page.
Costain Group PLC has announced a change in its voting rights structure following an acquisition by UBS Group AG, which now holds a 6.541474% stake in the company. This development may influence Costain’s strategic decisions and could have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (GB:COST) stock is a Hold with a £1.05 price target. To see the full list of analyst forecasts on Costain stock, see the GB:COST Stock Forecast page.
Costain Group PLC announced the successful passing of all resolutions at its 2025 Annual General Meeting. The resolutions, which included ordinary and special resolutions, were approved by the necessary majorities, reflecting strong shareholder support. This outcome underscores the company’s stable governance and strategic direction, potentially reinforcing stakeholder confidence and enhancing its market position.
The most recent analyst rating on (GB:COST) stock is a Hold with a £1.05 price target. To see the full list of analyst forecasts on Costain stock, see the GB:COST Stock Forecast page.
Costain Group PLC announced that its trading performance for the year is in line with expectations, with a strong forward work position and new contract wins, particularly in the nuclear energy sector. These contracts include significant projects with Urenco and Sizewell C, positioning Costain as a key player in the UK’s decarbonized energy initiatives. The company remains confident in its strategic growth prospects despite macroeconomic challenges.
The most recent analyst rating on (GB:COST) stock is a Hold with a £105.00 price target. To see the full list of analyst forecasts on Costain stock, see the GB:COST Stock Forecast page.
Costain Group PLC has announced a change in the voting rights held by Perpetual Limited, a shareholder based in Sydney, Australia. The notification indicates that Perpetual Limited’s voting rights in Costain have decreased from 9.910% to 4.919%, which may influence the company’s shareholder dynamics and potentially affect its decision-making processes.
Costain Group PLC announced an increase in its issued share capital to 272,566,087 ordinary shares as of April 30, 2025. This increase results from the allotment of shares to fulfill employee options under the Long Term Incentive Plan, impacting shareholder voting rights and interest calculations under FCA rules.
Costain Group PLC has announced the Scrip Dividend Reference Price for its shareholders who opt for the scrip dividend alternative for the final dividend of the year ending December 31, 2024. The price is set at 104.88 pence per ordinary share, calculated based on the average market value from the London Stock Exchange. This move allows shareholders to receive dividends in the form of additional shares rather than cash, potentially impacting the company’s cash flow and shareholder equity. The final dividend, subject to approval at the upcoming Annual General Meeting, will be paid on May 29, 2025.
UBS Group AG’s trading book holdings in Costain Group PLC have fallen below the 5% threshold, making them exempt from reporting obligations. This change in holdings may impact Costain’s shareholder structure and could influence market perceptions of the company’s stock, although the immediate operational impact on Costain is not specified.
UBS Group AG, through its Investment Bank & Global Wealth Management division, has acquired a significant voting rights stake in Costain Group PLC, reaching a threshold of 5.221284% as of April 17, 2025. This acquisition marks a notable change in the shareholder structure of Costain, potentially impacting its governance and strategic decisions, as UBS now holds a substantial influence in the company.
Costain Group PLC has announced the grant of share awards to its CEO, Alex Vaughan, and CFO, Helen Willis, under its 2023 Share Deferral Plan and Long Term Incentive Plan. These awards, which involve options over ordinary shares at a nil exercise price, are part of the company’s strategy to align executive incentives with long-term performance goals. The Share Deferral Plan awards will become exercisable two years from the grant date, while the Long Term Incentive Plan awards will vest after three years, contingent on meeting performance conditions. This move underscores Costain’s commitment to retaining key leadership and enhancing shareholder value.
Costain Group PLC has announced the details of its 2025 Annual General Meeting (AGM), scheduled for May 15, 2025, in London. Shareholders are encouraged to participate by voting and submitting questions in advance. The AGM Notice and the Annual Report for the year ending December 31, 2024, are now available online and through the National Storage Mechanism. The Board emphasizes the importance of informed voting and will provide responses to shareholder inquiries prior to the meeting.
Costain Group PLC has applied for the admission of 3,800,000 new ordinary shares to the UK Listing Authority’s Official List and the London Stock Exchange. This move is part of the company’s Long Term Incentive Plan, with shares expected to be admitted on 7 April 2025, enhancing the company’s capital structure and potentially impacting shareholder value.
Oasis Management Company Ltd., a Hong Kong-based entity, has acquired a significant financial instrument stake in Costain Group PLC, crossing the 5% threshold of voting rights. This acquisition could influence Costain’s strategic decisions and impact its market positioning, given Oasis Management’s substantial voting power.
Costain has been selected by Urenco as the programme delivery partner for a significant infrastructure upgrade at Urenco’s Capenhurst site in Cheshire. This partnership is part of Costain’s strategic focus on growth in strong markets, aiming to deliver a more prosperous, resilient, and decarbonised UK by leveraging their expertise in critical national infrastructure.
Costain Group PLC reported a robust financial performance for the year ended December 2024, with a record increase in its forward work position to £5.4 billion. Despite a slight decline in revenue to £1,251 million, the company achieved significant growth in adjusted operating profit, operating margins, and earnings per share. The company’s strategic focus on high-quality contracts and investment in chosen markets has resulted in improved financial metrics and increased confidence in future growth prospects. The doubling of the full-year dividend reflects the company’s strong cash position and commitment to enhancing shareholder returns.